Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.848
+0.042 (5.16%)
At close: Apr 28, 2026, 4:00 PM EDT
0.844
-0.004 (-0.41%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Humacyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Humacyte stock have an average target of 6.19, with a low estimate of 1.00 and a high estimate of 25. The average target predicts an increase of 630.38% from the current stock price of 0.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,849.85% | Apr 28, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +253.98% | Apr 28, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,849.85% | Apr 24, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,849.85% | Apr 21, 2026 |
| Barclays | Barclays | Buy Maintains $3.5 → $1.5 | Buy | Maintains | $3.5 → $1.5 | +76.99% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
11.09M
from 2.04M
Increased by 444.16%
Revenue Next Year
38.64M
from 11.09M
Increased by 248.39%
EPS This Year
-0.43
from -0.26
EPS Next Year
-0.33
from -0.43
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 15.9M | 51.7M | ||||||
| Avg | 11.1M | 38.6M | ||||||
| Low | 6.9M | 26.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 679.5% | 365.8% | ||||||
| Avg | 444.2% | 248.4% | ||||||
| Low | 236.6% | 134.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.36 | -0.28 | ||||||
| Avg | -0.43 | -0.33 | ||||||
| Low | -0.51 | -0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.